Nebivolol Tablets — Class III drug recall D-0222-2026
Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2025-12-17, distributed nationwide. Cross Contamination with Other Products
| Recall number | D-0222-2026 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2025-11-18 |
| Classified | 2025-12-09 |
| Reported by FDA | 2025-12-17 |
| Distributed | Nationwide (US) |
| NDC | 42291-0871, 42291-0871-30, 42291-0872, 42291-0872-90, 42291-0873, 42291-0873-90, 42291-0874, 42291-0874-90 |
| Lot numbers | 17240988 |
| Expiration dates | 2026-05-31 |
Product
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Reason for recall
Cross Contamination with Other Products
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0222-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.